Literature DB >> 11788361

Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis.

P Tessari1, R Barazzoni, E Kiwanuka, G Davanzo, G De Pergola, R Orlando, M Vettore, M Zanetti.   

Abstract

To investigate the anabolic effects of feeding in cirrhosis, we measured albumin fractional synthesis rate (FSR) and whole body protein synthesis in six nondiabetic patients with stable liver cirrhosis (three in the Child-Pugh classification Class A, three in Class B) and in seven normal control subjects, before and after administration of a 4-h mixed meal. Leucine tracer precursor-product relationships and whole body kinetics were employed at steady state. Basal levels of postabsorptive albumin concentration and FSR, whole body leucine rate of appearance, oxidation, and nonoxidative leucine disposal (NOLD, approximately equal to protein synthesis) were similar in the two groups. However, after the meal, in the patients neither albumin FSR (from 8.5 +/- 1.5 to 8.8 +/- 1.8 %/day) nor NOLD (from 1.69 +/- 0.22 to 1.55 +/- 0.26 micromol x kg(-1) x min(-1)) changed (P = nonsignificant vs. basal), whereas they increased in control subjects (albumin FSR: from 10.9 +/- 1.5 to 15.9 +/- 1.9 %/day, P < 0.002; NOLD: from 1.80 +/- 0.14 to 2.10 +/- 0.19 micromol x kg(-1) x min(-1), P = 0.032). Thus mixed meal ingestion did not stimulate either albumin FSR or whole body protein synthesis in compensated liver cirrhosis. The mechanism(s) maintaining normoalbuminemia at this disease stage need to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788361     DOI: 10.1152/ajpendo.00333.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

1.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

3.  Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.

Authors:  Cynthia Tsien; Gangarao Davuluri; Dharmvir Singh; Allawy Allawy; Gabriella A M Ten Have; Samjhana Thapaliya; John M Schulze; David Barnes; Arthur J McCullough; Marielle P K J Engelen; Nicolaas E P Deutz; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

Review 4.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

Review 5.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

Review 6.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

7.  Consilience in sarcopenia of cirrhosis.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

Review 8.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

Authors:  David G Levitt; Michael D Levitt
Journal:  Int J Gen Med       Date:  2016-07-15

9.  Quantitative analysis of amino acid metabolism in liver cancer links glutamate excretion to nucleotide synthesis.

Authors:  Avlant Nilsson; Jurgen R Haanstra; Martin Engqvist; Albert Gerding; Barbara M Bakker; Ursula Klingmüller; Bas Teusink; Jens Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

Review 10.  Emerging Treatment Options for Sarcopenia in Chronic Liver Disease.

Authors:  Yun Kim
Journal:  Life (Basel)       Date:  2021-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.